You have 9 free searches left this month | for more free features.

E-602

Showing 1 - 25 of 5,480

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Oncology, Melanoma, Ovarian Cancer Trial in United States (E-602, Pembrolizumab)

Recruiting
  • Oncology
  • +16 more
  • E-602
  • Pembrolizumab
  • Grand Rapids, Michigan
  • +4 more
May 27, 2022

Acute Promyelocytic Leukemia Trial in Worldwide (Mylotarg, Arsenic Trioxide, All-trans retinoic acid)

Recruiting
  • Acute Promyelocytic Leukemia
  • Brussels, Belgium
  • +30 more
Aug 9, 2022

Achondroplasia Trial in Worldwide (Recifercept)

Active, not recruiting
  • Achondroplasia
  • Recifercept
  • Irvine, California
  • +13 more
Jan 20, 2023

Endometriosis Trial in Japan (Dydrogesterone)

Completed
  • Endometriosis
  • Tokyo, Chiyodaku, Japan
  • +14 more
Jun 13, 2022

Achondroplasia Trial in Worldwide (Recifercept)

Recruiting
  • Achondroplasia
  • Recifercept
  • Aliso Viejo, California
  • +13 more
Aug 3, 2022

Coronary Artery Disease Trial in Korea, Republic of (Prasugrel 5mg, Ticagrelor 60mg)

Unknown status
  • Coronary Artery Disease
  • Prasugrel 5mg
  • Ticagrelor 60mg
  • Changwon, Gyeongsangnam-do, Korea, Republic of
  • +7 more
Jan 28, 2021

Transfusional Iron Overload, Beta-Thalassemia Trial in Worldwide (SPD602)

Terminated
  • Transfusional Iron Overload
  • Beta-Thalassemia
  • Boston, Massachusetts
  • +8 more
Jun 10, 2021

Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck Trial in Worldwide (E7050, Cetuximab)

Completed
  • Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck
  • Tucson, Arizona
  • +22 more
Dec 3, 2021

Iron Overload Due to Repeated Red Blood Cell Transfusions Trial in Worldwide (SPD602)

Terminated
  • Iron Overload Due to Repeated Red Blood Cell Transfusions
  • Los Angeles, California
  • +11 more
Jun 11, 2021

Acute Myeloid Leukemia, Myeloid Dysplastic Syndrome Trial in Worldwide (Guadecitabine)

Terminated
  • Acute Myeloid Leukemia
  • Myeloid Dysplastic Syndrome
  • Buffalo, New York
  • +20 more
Jan 21, 2022

Erosive Esophagitis Trial in Worldwide (Dexlansoprazole)

Not yet recruiting
  • Erosive Esophagitis
  • Mobile, Alabama
  • +44 more
Jun 13, 2022

Leukemia, Myeloid, Acute, MDS Trial in Worldwide (CC-90009)

Recruiting
  • Leukemia, Myeloid, Acute
  • Myelodysplastic Syndromes
  • New Haven, Connecticut
  • +23 more
Aug 1, 2022

Transfusional Iron Overload, Beta-thalassemia Trial in Worldwide (SPD602 (FBS0701, SSP-004184))

Completed
  • Transfusional Iron Overload
  • Beta-thalassemia
  • SPD602 (FBS0701, SSP-004184)
  • Oakland, California
  • +8 more
May 30, 2021

Clinical & Anthropometric Characteristics of Achondroplasia.

Active, not recruiting
  • Achondroplasia
    • Torrance, California
    • +32 more
    Nov 16, 2022

    Pancreatic Tumors Trial in Worldwide (BAY86-9766+Gemcitabine)

    Completed
    • Pancreatic Neoplasms
    • Aurora, Colorado
    • +22 more
    Apr 6, 2021

    Relapsing-Remitting Multiple Sclerosis Trial in Worldwide (Ocrelizumab, Ocrelizumab Placebo, Fingolimod)

    Recruiting
    • Relapsing-Remitting Multiple Sclerosis
    • La Jolla, California
    • +66 more
    Jan 27, 2023

    Eczema, Atopic Dermatitis Trial in Worldwide (KY1005, Placebo)

    Active, not recruiting
    • Eczema
    • Atopic Dermatitis
    • Fremont, California
    • +102 more
    Dec 13, 2022

    Hidradenitis Suppurativa (HS) Trial in Worldwide (Upadacitinib, Placebo Upadacitinib)

    Completed
    • Hidradenitis Suppurativa (HS)
    • Phoenix, Arizona
    • +25 more
    Mar 22, 2022

    The BCI 602 BONEBRIDGE Post-Market Clinical Follow-up Study

    Recruiting
    • Hearing Loss
    • +5 more
    • Bone Conduction Implant
    • Innsbruck, Austria
    • +7 more
    Jan 21, 2022

    Hidradenitis Suppurativa Trial in Worldwide (Lutikizumab, Placebo)

    Recruiting
    • Hidradenitis Suppurativa
    • Lutikizumab
    • Placebo
    • Phoenix, Arizona
    • +54 more
    Jan 26, 2023

    Tumors Trial in Worldwide (CC-95251, Rituximab, Cetuximab)

    Recruiting
    • Neoplasms
    • Birmingham, Alabama
    • +62 more
    Jan 19, 2023

    Hemophilia Trial in Worldwide (Fitusiran)

    Completed
    • Hemophilia
    • Little Rock, Arkansas
    • +43 more
    May 11, 2022

    HBV, Chronic HBV Infection Trial in Worldwide (TAF, TDF, TAF Placebo)

    Active, not recruiting
    • HBV
    • Chronic HBV Infection
    • Los Angeles, California
    • +159 more
    Mar 17, 2022

    Multiple Myeloma Trial in Worldwide (Elranatamab, Lenalidomide)

    Recruiting
    • Multiple Myeloma
    • Benowa, Queensland, Australia
    • +132 more
    Jan 24, 2023

    Endometriosis Trial in Worldwide (75 mg linzagolix tablet, 200 mg linzagolix tablet, Placebo tablet to match 75 mg linzagolix

    Active, not recruiting
    • Endometriosis
    • 75 mg linzagolix tablet
    • +5 more
    • Dothan, Alabama
    • +46 more
    Jan 12, 2023